Navigation Links
New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
Date:2/7/2008

BRIDGEWATER, N.J., Feb. 7 /PRNewswire/ -- New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) had an undetectable viral load (defined as less than 50 HIV-1 RNA copies/mL) with INTELENCE (etravirine) tablets plus a background regimen (BR) compared with placebo plus a BR. These findings from two ongoing double-blind, placebo-controlled, randomized Phase 3 studies (DUET-1 and DUET-2) were presented at the 15th Conference on Retroviruses and Opportunistic Infections in Boston.

In the DUET-1 and -2 studies, 60 percent and 61 percent of patients in the INTELENCE arms had a confirmed undetectable viral load at 48 weeks compared with 39 percent and 41 percent of those in the placebo arms, respectively. In each study, this difference was significant [p<0.0001].

INTELENCE, a new NNRTI from Tibotec, received accelerated approval from the U.S. Food and Drug Administration (FDA) on January 18, 2008. It is the first NNRTI to receive approval in almost ten years. INTELENCE received approval based on the 24-week analysis of HIV viral load and CD4+ cell counts from the pooled DUET-1 and -2 studies. The 48-week results will be filed with the FDA for consideration of traditional approval of INTELENCE.

"Etravirine is an important new option for treatment-experienced patients with NNRTI resistance and these data build upon the 24-week data that had previously been available," said Richard Haubrich, M.D., Professor of Medicine, Division of Infectious Diseases, University of California, San Diego, and investigator in the INTELENCE Phase 3 DUET studies.

INTELENCE, in combination with other antiretroviral (ARV) agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients, who have evidence of viral replication an
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
2. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
3. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
4. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
5. Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
6. Vanda Presents Phase III Iloperidone Efficacy Data
7. Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting
8. TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
10. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
11. Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
(Date:11/26/2014)... Oregon , November 26, 2014 ... fascia of the organ protrudes through the wall of a ... muscle area at birth are some of the causes of ... umbilical, hiatal, femoral, and incisional. An inguinal hernia is when ... An umbilical hernia is found in the area of the ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3New Pain Management Center Opens in Cumberland, Md. 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
... IRVINE, Calif., Feb. 15, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the presentation of the ... 2011 iCON (International Congress of Endovascular Specialists) annual meeting ... Roll-In phase of the trial, technical success rates of ...
... 15, 2011 Daiichi Sankyo, Inc. (DSI), today announced ... Bethlehem Township, Pennsylvania from Amcor, a global packaging manufacturer. ... resources to more cost-effectively supplement its operations rather than ... be operational in the summer or early fall of ...
Cached Medicine Technology:Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 2Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 3Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2
(Date:11/28/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Celebration ... are misused on Thanksgiving Day, experts say. Over ... hot-oil burns have occurred while people were using turkey ... "I have actually cared for a patient who ... should not be done in any circumstances," Dr. Arthur ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
(Date:11/28/2014)... New York, New York (PRWEB) November 28, 2014 ... lawsuits ( http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/ ) have now been filed ... pair of recalled metal implants, Bernstein Liebhard LLP ... November 18th in Bergen County Superior Court reflects ... and ABG II modular-neck hip stems, which were ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Patten Pecans, ... locally grown. With those passions driving them, they've added ... Grown. Having tried other pecans oils, they've found this ... Georgia to be exceptionally flavorful, retaining the buttery pecan ... same nutritional benefits found in pecans nuts ...
(Date:11/28/2014)... Before that Thanksgiving meal even had time to digest, ... season. Today, people will stand in line for hours to ... shopping day of the year. , But instead of ... dentist Dr. Ronald Receveur is asking the public to ... brighten a few smiles. , The gifts he suggests are:, ...
Breaking Medicine News(10 mins):Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 3Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 4
... type of skin cancer. In this paper, Leif Ellisen and ... and p73 in SCC cells, and discovered a feedback loop ... SCC, they found that inhibiting one of these miRs decreased ... highlighting a new potential therapeutic target. , Squamous cell carcinoma ...
... Reinberg HealthDay Reporter , SUNDAY, Jan. 9 ... (best known by the brand name of Prozac) appear ... sufferers, French researchers have found. Not surprisingly, patients ... depression after their stroke, the study found. Paralysis ...
... The search for a universal flu vaccine has received a ... strain. Several patients infected with the 2009 H1N1 strain ... strains, scientists from Emory University School of Medicine and the ... Monday in the Journal of Experimental Medicine . ...
... Hope for new ways of treating devastating neurodegenerative disorders ... trans-Atlantic team of researchers thanks to the use of ... Leicester, scientists from the University of Lisbon (led by ... Francisco (led by Dr Paul Muchowski) collaborated to generate ...
... areas of the United States are more likely to ... areas, particularly when comparing non-whites living in different parts ... new study published early online in Cancer , ... research is needed to better understand how colorectal cancer ...
... (HealthDay News) -- The first study to focus solely on ... the Sept. 11, 2001 attacks on the World Trade Center ... fact, of the 3,271 evacuees of the Twin Towers surveyed ... from at least one current post-traumatic stress symptom, while 15 ...
Cached Medicine News:Health News:Prozac May Speed Physical Rehabilitation After Stroke 2Health News:Prozac May Speed Physical Rehabilitation After Stroke 3Health News:Pandemic flu strain could point way to universal vaccine 2Health News:Pandemic flu strain could point way to universal vaccine 3Health News:New hope in fight against Huntington's disease 2Health News:Race affects regional colorectal cancer screening disparities 2Health News:Many Survivors of World Trade Center Attacks Suffered PTSD: Study 2
... Cobas Integra 400 plus, innovation means ... of reaction cuvettes and im-proved operator ... menu and ease-of-use required for true ... only possible with only one analytical ...
... The Advia 1650 has ... (as low as 2 L/test), ... 80 L/test) and water consumption ... management efficiency. Optional universal rack ...
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
HDL Cholesterol, liquid....
Medicine Products: